Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Explainer-What will change with the US reclassification of marijuana? - 2Roche breast cancer pill cuts risk of disease recurrence by 30% in trial
- 3Watch interstellar comet 3I/ATLAS speed away from the sun in free telescope livestream on Nov. 16
- 4'No Kings' protests recap: More than 8 million turned out across all 50 states, organizers say
- 5UN warns civil liberties under threat due to war in Middle East
- Step by step instructions to Protect Your Speculations with Cd Rates
- Vote In favor of Your Favored Kind Of Bites
- Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- Vacuum Cleaners That Are Not difficult To Use For Home
- Emergent Cold LatAm opens state-of-the-art cold storage hub in Guadalajara
- Manual for 6 well known Amusement Park
- Vote In favor of Your Favored Sort Of Dress
- ‘Aid for Ukraine’ pierogi fundraiser event
- The Effect of Online Organizations on Society: Beating the Difficulties
